Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (231-240 of 418) with videos related to

Pageof 42
Sort By:
Journal of Drugs in Dermatology : JDD|February 21, 2018
Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEILLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|April 7, 2007
Water content and other aspects of brittle versus normal fingernailsDana Kazlow Stern, Stephanie Diamantis, Elizabeth Smith, et al.
Journal of the American Academy of Dermatology|September 23, 2014
A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasisKenneth B Gordon, Craig L Leonardi, Mark Lebwohl, et al.
Dermatology and Therapy|May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT SurveyJoseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
JAMA Dermatology|September 18, 2014
Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trialHenry W Lim, Pearl E Grimes, Oma Agbai, et al.
The New England Journal of Medicine|February 9, 2007
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasisGerald G Krueger, Richard G Langley, Craig Leonardi, et al.
The Cochrane Database of Systematic Reviews|February 27, 2013
Interventions for nail psoriasisAnna Christa Q de Vries, Nathalie A Bogaards, Lotty Hooft, et al.
The Journal of Dermatological Treatment|December 11, 2023
Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registryBruce Strober, Kristina Callis Duffin, Mark Lebwohl, et al.
The New England Journal of Medicine|February 13, 2023
Phase 2 Trial of Difelikefalin in Notalgia ParestheticaBrian S Kim, Robert Bissonnette, Kristine Nograles, et al.
Journal of the American Academy of Dermatology|April 21, 2004
Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsMark Lebwohl, Scott Dinehart, David Whiting, et al.
Pageof 42

Showing results (231-240 of 418) with videos related to

Sort By:
Pageof 42
Journal of Drugs in Dermatology : JDD|February 21, 2018
Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEILLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|April 7, 2007
Water content and other aspects of brittle versus normal fingernailsDana Kazlow Stern, Stephanie Diamantis, Elizabeth Smith, et al.
Journal of the American Academy of Dermatology|September 23, 2014
A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasisKenneth B Gordon, Craig L Leonardi, Mark Lebwohl, et al.
Dermatology and Therapy|May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT SurveyJoseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
JAMA Dermatology|September 18, 2014
Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trialHenry W Lim, Pearl E Grimes, Oma Agbai, et al.
The New England Journal of Medicine|February 9, 2007
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasisGerald G Krueger, Richard G Langley, Craig Leonardi, et al.
The Cochrane Database of Systematic Reviews|February 27, 2013
Interventions for nail psoriasisAnna Christa Q de Vries, Nathalie A Bogaards, Lotty Hooft, et al.
The Journal of Dermatological Treatment|December 11, 2023
Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registryBruce Strober, Kristina Callis Duffin, Mark Lebwohl, et al.
The New England Journal of Medicine|February 13, 2023
Phase 2 Trial of Difelikefalin in Notalgia ParestheticaBrian S Kim, Robert Bissonnette, Kristine Nograles, et al.
Journal of the American Academy of Dermatology|April 21, 2004
Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsMark Lebwohl, Scott Dinehart, David Whiting, et al.
Pageof 42